LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 38.22 | 771.67 | 3891 | 4299 | 0.9050 | 0.9210 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 40.44 | 771.67 | 4857 | 4738 | 1.0250 | 1.0190 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 40.44 | 771.67 | 4339 | 4738 | 0.9157 | 0.9339 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 42.67 | 771.67 | 5328 | 5155 | 1.0334 | 1.0241 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 42.67 | 771.67 | 4751 | 5155 | 0.9215 | 0.9412 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 44.89 | 771.67 | 5641 | 5541 | 1.0180 | 1.0126 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 44.89 | 771.67 | 5050 | 5541 | 0.9113 | 0.9358 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.11 | 771.67 | 6008 | 5941 | 1.0112 | 1.0076 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.11 | 771.67 | 5534 | 5941 | 0.9314 | 0.9523 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 49.33 | 771.67 | 6474 | 6392 | 1.0127 | 1.0083 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 49.33 | 771.67 | 5902 | 6392 | 0.9233 | 0.9483 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 51.55 | 771.67 | 7034 | 6829 | 1.0299 | 1.0188 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 51.55 | 771.67 | 6385 | 6829 | 0.9349 | 0.9576 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 53.77 | 771.67 | 7589 | 7256 | 1.0458 | 1.0279 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 53.77 | 771.67 | 6790 | 7256 | 0.9357 | 0.9593 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 55.99 | 771.67 | 8041 | 7690 | 1.0456 | 1.0271 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 55.99 | 771.67 | 7340 | 7690 | 0.9545 | 0.9721 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 58.21 | 771.67 | 8529 | 8085 | 1.0549 | 1.0318 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 58.21 | 771.67 | 7770 | 8085 | 0.9610 | 0.9767 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 60.44 | 771.67 | 8961 | 8530 | 1.0505 | 1.0286 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 60.44 | 771.67 | 8239 | 8530 | 0.9658 | 0.9800 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 62.66 | 771.67 | 9314 | 8978 | 1.0374 | 1.0208 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 62.66 | 771.67 | 8689 | 8978 | 0.9678 | 0.9816 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 64.88 | 771.67 | 9765 | 9447 | 1.0336 | 1.0184 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 64.88 | 771.67 | 9182 | 9447 | 0.9719 | 0.9843 | MN20160304_L01 | G18 |